Product containing allopurinol and lesinurad (medicinal product)
RxNorm 1944778
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1944778 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Product containing allopurinol and lesinurad (medicinal product).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
MINPrescribable
Multiple Ingredients (MIN):
Allopurinol / lesinurad
(Atom ID: 12351076)
PTPrescribable
Designated preferred name (PT):
Allopurinol- and lesinurad-containing product
(Atom ID: 10795961)
FNPrescribable
Full form of descriptor (FN):
Product containing allopurinol and lesinurad (medicinal product)
(Atom ID: 10304046)
Patient Education
Allopurinol
Allopurinol is used to treat gout, high levels of uric acid in the body caused by certain cancer medications, and kidney stones. Allopurinol is in a class of medications called xanthine oxidase inhibitors. It works by reducing the production of uric acid in the body. High levels of uric acid may cause gout attacks or kidney stones. Allopurinol is used to prevent gout attacks, not to treat them once they occur.
[Learn More]
Lesinurad
Lesinurad is used in combination with a xanthine oxidase inhibitor to treat hyperuricemia (high levels of uric acid) in people with gout (sudden attacks of redness, swelling, pain, and heat in one or more joints) whose disease is not controlled with their current medication. Lesinurad is in a class of medications called selective uric acid reabsorption inhibitors. It works by helping the kidneys to remove uric acid from the body.
[Learn More]
* Please review the disclaimer below.